Acute puerperal uterine inversion: two-step management with a beta-mimetic and a prostaglandin.
Sequential administration of a beta 2-mimetic and a prostaglandin, the latter preferably injected into the uterus, is a simple and highly effective method for managing acute puerperal uterine inversion.
D002260:Carboprost / Q000627:therapeutic use*; D015232:Dinoprostone; D004359:Drug Therapy, Combination; D005260:Female; D005280:Fenoterol / Q000627:therapeutic use*; D006801:Humans; D011247:Pregnancy; D011458:Prostaglandins E / Q000627:therapeutic use*; D011459:Prostaglandins E, Synthetic / Q000627:therapeutic use*; D011461:Prostaglandins F, Synthetic / Q000627:therapeutic use*; D011644:Puerperal Disorders / Q000188:drug therapy*; D012312:Ritodrine / Q000627:therapeutic use*; D014591:Uterine Diseases / Q000188:drug therapy*
D011458:Prostaglandins E; D011459:Prostaglandins E, Synthetic; D011461:Prostaglandins F, Synthetic; D005280:Fenoterol; D002260:Carboprost; D012312:Ritodrine; D015232:Dinoprostone